Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nivolumab-Induced Colitis Treated by Infliximab.

× No keyword cloud information.

18 in total

Review 1. Workup and Management of Immune-Mediated Colitis in Patients Treated with Immune Checkpoint Inhibitors.

Authors: Bhavana Pendurthi Singh; John L Marshall; Aiwu Ruth He
Journal: Oncologist Date: 2019-09-06

Review 2. Identifying and managing the adverse effects of immune checkpoint blockade.

Authors: Arthur Winer; J Nicholas Bodor; Hossein Borghaei
Journal: J Thorac Dis Date: 2018-02 Impact factor: 2.895

3. Workup and Management of Immune-Mediated Colitis in Patients Treated with Immune Checkpoint Inhibitors.

Authors: Bhavana Pendurthi Singh; John L Marshall; Aiwu Ruth He
Journal: Oncologist Date: 2019-09-06

4. Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis.

Authors: Andrew P Wright; Marc S Piper; Shrinivas Bishu; Ryan W Stidham
Journal: Aliment Pharmacol Ther Date: 2019-04-29 Impact factor: 8.171

Review 5. Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.

Authors: Christopher Ma; John K MacDonald; Tran M Nguyen; Niels Vande Casteele; Bryan Linggi; Pavine Lefevre; Yinghong Wang; Brian G Feagan; Vipul Jairath
Journal: Dig Dis Sci Date: 2021-03-26 Impact factor: 3.199

Review 6. Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis.

Authors: Sae Ohwada; Keisuke Ishigami; Noriyuki Akutsu; Hiroshi Nakase
Journal: Biomedicines Date: 2022-06-06

Review 7. The current state of the art for biological therapies and new small molecules in inflammatory bowel disease.

Authors: Sudarshan Paramsothy; Adam K Rosenstein; Saurabh Mehandru; Jean-Frederic Colombel
Journal: Mucosal Immunol Date: 2018-06-15 Impact factor: 7.313

Review 8. Ipilimumab-Induced Enterocolitis: A Systematic Review and Meta-Analysis.

Authors: Kelcie Witges; Leigh Anne Shafer; Ryan Zarychanski; Ahmed M Abou-Setta; Rasheda Rabbani; Orvie Dingwall; Charles N Bernstein
Journal: Drug Saf Date: 2020-12 Impact factor: 5.606

9. Osimertinib reactivated immune-related colitis after treatment with anti-PD1 antibody for non-small cell lung cancer.

Authors: Tomoyoshi Takenaka; Koji Yamazaki; Naoko Miura; Naohiko Harada; Sadanori Takeo
Journal: Invest New Drugs Date: 2017-06-10 Impact factor: 3.850

10. Readministration of Nivolumab after Persistent Immune-related Colitis in a Patient with Recurrent Melanoma.

Authors: Yosuke Fujii; Yoshitaka Nishikawa; Motoo Nomura; Shin'ich Miyamoto; Yu Uneno; Takahiro Horimatsu; Manabu Muto
Journal: Intern Med Date: 2017-12-21 Impact factor: 1.271